Scarica l'app Stockscreener
1.40
1.45%
0.02
Dopo l'orario di chiusura:
1.40
Precedente Chiudi:
$1.38
Aprire:
$1.39
Volume 24 ore:
926.61K
Relative Volume:
0.34
Capitalizzazione di mercato:
$372.60M
Reddito:
$51.25M
Utile/perdita netta:
$-224.64M
Rapporto P/E:
-1.6586
EPS:
-0.8441
Flusso di cassa netto:
$-306.93M
1 W Prestazione:
-1.41%
1M Prestazione:
+2.19%
6M Prestazione:
-23.91%
1 anno Prestazione:
-27.84%
Intervallo 1D:
$1.385
$1.44
Intervallo di 1 settimana:
$1.3645
$1.48
Portata 52W:
$1.105
$2.70
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Nome
Autolus Therapeutics Plc Adr
Settore
Industria
Telefono
44 20 3829 6230
Indirizzo
THE MEDIAWORKS, LONDON
Compare AUTL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.40 | 367.28M | 51.25M | -224.64M | -306.93M | -0.8441 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-18 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-11-15 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-03-27 | Ripresa | Wells Fargo | Overweight |
| 2023-03-17 | Iniziato | Bryan Garnier | Buy |
| 2021-06-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-01-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Ripresa | H.C. Wainwright | Buy |
| 2020-07-31 | Iniziato | JP Morgan | Overweight |
| 2020-07-22 | Iniziato | SunTrust | Buy |
| 2020-04-22 | Iniziato | Mizuho | Buy |
| 2019-09-23 | Iniziato | Needham | Buy |
| 2019-05-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-10-24 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Autolus Therapeutics Plc Adr Borsa (AUTL) Ultime notizie
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
New Strong Sell Stocks for January 30th - Yahoo Finance
Autolus Therapeutics (NASDAQ:AUTL) Cut to Strong Sell at Zacks Research - Defense World
New Strong Sell Stocks for January 22nd - Yahoo! Finance Canada
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Silver Viper Minerals (CVE:VIPR) Trading Down 15.3% – Here’s What Happened - Defense World
Free cash flow per share of Autolus Therapeutics Plc Sponsored ADR – FWB:6A3A - TradingView — Track All Markets
Autolus Therapeutics (NASDAQ:AUTL) Price Target Raised to $11.00 at Needham & Company LLC - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Trading Up 13.5% Following Analyst Upgrade - Defense World
Autolus Therapeutics stock jumps after Needham raises price target By Investing.com - Investing.com South Africa
Needham raises Autolus Therapeutics stock price target on Aucatzyl launch success - Investing.com
Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Finviz
Perpetual Ltd Has $784,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
The i-80 Gold Corp (IAUX) had a good session last reading, didn’t it? - uspostnews.com
Autolus Therapeutics’ (AUTL) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Views of Wall Street’s Leading Experts on Autolus Therapeutics plc ADR - setenews.com
Wall Street analysts’ outlook for AlphaVest Acquisition Corp (ATMV) - setenews.com
Check Out Autolus Therapeutics plc ADR (AUTL)’s Trade Data Rather Than the Analysts’ Views - Setenews
Cetera Investment Advisers Has $1.41 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com
An analyst sees good growth prospects for Autolus Therapeutics plc ADR (AUTL) - Setenews
Taking on analysts’ expectations and winning: EON Resources Inc (EONR) - Setenews
Ready to Jump After Recent Trade: BitMine Immersion Technologies Inc (BMNR) - Setenews
Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Taking on analysts’ expectations and winning: enVVeno Medical Corporation (NVNO) - Setenews
Check out these key findings about Streamex Corp (STEX) - Setenews
This trade activity should not be overlooked: ETHZilla Corp (ETHZ) - Setenews
A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
How does Advanced Biomed Inc (ADVB) change from a tortoise to a hare? - Setenews
A look into Mobile health Network Solutions (MNDR)’s deeper side - Setenews
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Taking on analysts’ expectations and winning: Gelteq Ltd (GELS) - Setenews
Wall Street analysts’ outlook for Amaze Holdings Inc (AMZE) - Setenews
Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? - Finviz
NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹ - GlobeNewswire Inc.
Autolus Therapeutics Surges: What’s Next for the Stock? - StocksToTrade
ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
A new trading data show Ashford Hospitality Trust Inc (AHT) is showing positive returns. - Setenews
Taking on analysts’ expectations and winning: Houston American Energy Corp (HUSA) - Setenews
Does Klotho Neurosciences Inc (KLTO) offer a good opportunity for investors? - Setenews
The time has not yet come to remove your chips from the table: Psyence Biomedical Ltd (PBM) - Setenews
Newsmax Inc (NMAX) can make a big difference with a little luck - Setenews
Check Out Dolly Varden Silver Corp (DVS)’s Trade Data Rather Than the Analysts’ Views - Setenews
Views of Wall Street’s Leading Experts on Viomi Technology Co Ltd ADR - Setenews
Are Smart Investors Making the Right Decision? Empery Digital Inc (EMPD) - Setenews
Wall Street analysts’ outlook for Picard Medical Inc (PMI) - Setenews
Autolus Therapeutics plc ADR (AUTL) is looking forward to a strong quarter - Setenews
Views of Wall Street’s Leading Experts on Twin Vee PowerCats Co - Setenews
This trade activity should not be overlooked: Amaze Holdings Inc (AMZE) - Setenews
Wall Street analysts’ outlook for Cypherpunk Technologies Inc (CYPH) - Setenews
Autolus Therapeutics Plc Adr Azioni (AUTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):